COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Immunity, ISSN: 1074-7613, Vol: 52, Issue: 5, Page: 731-733
2020
- 630Citations
- 999Captures
- 10Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations630
- Citation Indexes629
- 629
- CrossRef561
- Policy Citations1
- Policy Citation1
- Captures999
- Readers999
- 999
- Mentions10
- News Mentions8
- News8
- References2
- Wikipedia2
Most Recent News
Role of Inflammation in the Development of COVID-19 to Parkinson’s Disease
Introduction Coronavirus disease 2019 (COVID-19) was initially identified in December 2019 in the city of Wuhan, China. Since then, it has rapidly spread across the
Article Description
Zhou et al. ( Nature ) and Hoffmann et al. ( Cell ) identify ACE2 as a SARS-CoV-2 receptor, and the latter show its entry mechanism depends on cellular serine protease TMPRSS2. These results may explain proinflammatory cytokine release via the associated angiotestin II pathway and a possible therapeutic target via the IL-6-STAT3 axis.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1074761320301618; http://dx.doi.org/10.1016/j.immuni.2020.04.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85083488868&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/32325025; https://linkinghub.elsevier.com/retrieve/pii/S1074761320301618; https://dx.doi.org/10.1016/j.immuni.2020.04.003; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8; http://www.cell.com/article/S1074761320301618/abstract; http://www.cell.com/article/S1074761320301618/fulltext; http://www.cell.com/article/S1074761320301618/pdf; https://www.cell.com/immunity/abstract/S1074-7613(20)30161-8; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8?dgcid=raven_jbs_aip_email#.XqFOAr7nFpA.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8?dgcid=raven_jbs_aip_email; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8#.XqWXI3auX78.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8#.Xs0CAYsAy-U.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8#.XqDI2NF7X78.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8#.Xq9rttDaEcU.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8#.XqM2Or7jiMc.twitter; https://www.cell.com/immunity/fulltext/S1074-7613(20)30161-8?dgcid=raven_jbs_aip_email#.XqFTsQnJtS8.twitter
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know